Pharmaceuticals

U.S. Sucralfate Market to Grow with Rising Demand for Peptic Ulcer Treatment

Purvaja

U.S. Sucralfate Market to Grow with Rising Demand for Peptic Ulcer Treatment

The U.S. sucralfate market consists of antacid formulation used for the treatment of peptic ulcers. Sucralfate selectively coats and protects ulcers from stomach acids and digestive enzymes allowing natural healing. Its unique mechanism of action makes it suitable for patients who cannot tolerate long-term acid suppression therapies.

The Global U.S. Sucralfate Market Demand is estimated to be valued at US$ 70.05 Mn in 2024 and is expected to exhibit a CAGR of 5.6% over the forecast period 2024 to 2030.

Key Takeaways

Key players operating in the U.S. sucralfate market are Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc, Novartis AG, Sanofi S.A., Johnson & Johnson, Abbott Laboratories, Eli Lilly and Company, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Roche Holding AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Allergan plc. The key players dominate the market and focus on new product development and launches.

The U.S. sucralfate market provides significant opportunities for players engaged in product development for resistant strains of Helicobacter pylori infections. The companies focus on expanding their product portfolio and manufacturing facilities to cater to the growing demand.

The sucralfate market witnesses high demand in the U.S. due to the increasing prevalence of gastric ulcers. Most key players expand their presence across the country through strategic partnerships and collaborations with regional players. This allows them to penetrate untapped markets and strengthen supply chain operations.

Market drivers

The rising incidences of peptic ulcers caused due to NSAID use and H. pylori infection are major market drivers. Sucralfate protects ulcer sites from further damage, aids healing, and reduces risk of reoccurrences. Favorable reimbursement policies and patient assistance programs also support the market growth. Its effectiveness as a first-line treatment complements the demand.

PEST Analysis

Political: The pharmaceutical industry adheres to strict regulations imposed by regulatory bodies like the US Food and Drug Administration. Changes in regulations or other policies regarding drug approvals can impact the market.

Economic: Economic downturns can reduce healthcare spending and negatively influence the demand for sucralfate products. Recovery in the economy positively impacts the market.

Social: As life expectancy increases, the aging population is more susceptible to gastrointestinal diseases requiring sucralfate treatment. Growing health awareness also supports market growth.

Technological: Advancements in drug delivery systems help improve patient compliance for sucralfate treatment of ulcers. Technological developments also aid new product development, though regulatory approval times can impact product launches.

The U.S. market accounts for a major share of the global sucralfate market in terms of value. Factors such as high healthcare expenditure, growing pharmaceutical industry, and presence of key market players have supported market concentration in the U.S.

The Asia Pacific region is projected to be the fastest growing market during the forecast period. Rapidly developing healthcare systems, rising disposable incomes, growing medical tourism, and increasing ulcer disease prevalence are some key factors augmenting the sucralfate demand in Asia Pacific countries.

Get more insights on this topic: U.S. Sucralfate Market

Purvaja

The global U.S. Sucralfate Market Growth Accelerated by Increasing GERD Cases

Ishika cmi 2024-01-17

The global U. 8 Mn in 2023 and is expected to exhibit a CAGR of 5. 6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. is a major factor augmenting the sucralfate market growth. Segment AnalysisThe US sucralfate market is dominated by the oral suspension segment, which accounts for nearly 70% share of the overall market. The global U. 8 Mn in 2023 and is expected to exhibit a CAGR of 5.

U.S. Sucralfate Market Is Estimated To Witness High Growth Owing To Increasing Incidences of Gastric Ulcers

Pooja salve 2023-09-01

There is a significant need for sucralfate in the market due to the high prevalence of gastric ulcers, particularly in the U. The demand for sucralfate is expected to grow as more individuals are diagnosed with gastric ulcers and seek effective treatment options. - Social: The prevalence of gastric ulcers and awareness about their treatment options among the population are social factors affecting the sucralfate market. 1% over the forecast period, due to increasing incidences of gastric ulcers. The high prevalence of gastric ulcers, well-established healthcare infrastructure, and availability of various treatment options contribute to this growth.

Unveiling the Hidden Gems: Exploring U.S. Compounding Pharmacies

Larry Paige 2023-06-15

Understanding the intricacies of these pharmacies is essential for healthcare professionals, patients, and caregivers alike. These pharmacies specialize in creating customized medications tailored to individual needs. By combining different ingredients, these offer personalized solutions that traditional pharmacies cannot match. They provide a lifeline for patients with unique requirements, including allergies, sensitivities, and alternative dosage forms. Together, stakeholders can unlock the true potential of U.

Cloud Computing Is Fastest Growing Segment Fueling The Growth Of U.S. Sucralfate Market

samruddhicmi12 2023-12-13

It is available in various formulations including tablets and suspension for oral administration depending on patients' conditions. This has driven the preference of doctors and patients for sucralfate oral suspension over tablets. Among these, the suspension segment dominates the market with over 65% share owing to its increased preference among patients and caregivers. Factors such as the availability of advanced healthcare facilities and reimbursement policies are boosting the sucralfate market in Northeast U. Sanofi holds the highest market share due to its successful brand Alomide, which is available as tablets and suspension.

Trends Shaping the U.S. Healthcare Staffing Industry

Sneha 2024-03-19

With more patients requiring care, there is a growing need for healthcare professionals to provide those services across the country. Changing Models of Care DeliveryThe healthcare industry is also undergoing a major transition as it shifts from fee-for-service to value-based care models that focus on preventative care and population health management. The Role of Staffing AgenciesTo help address these staffing challenges, hospitals, clinics and other healthcare organizations increasingly rely on U. According to research from Staffing Industry Analysts, the U. As the healthcare industry undergoes transformations, adequate and flexible staffing will remain critical to quality care delivery.

The global U.S. Nasal Spray Market Growth Accelerated by Increasing Prevalence of Allergies

Sumedha 2024-01-04

Demand for nasal sprays is increasing owing to rising prevalence of allergic rhinitis and sinusitis conditions among people. 5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. As per American Academy of Allergy Asthma & Immunology (AAAAI), more than 60 million Americans experience allergic rhinitis yearly. This growing patient pool experiencing nasal blockage and other allergy symptoms will continue driving demand for effective nasal spray medications over the forecast period. Companies operating in this market have an opportunity to launch new products targeting specific allergy types and expand existing line of nasal sprays to cash-in on increased need for relief from nasal congestion and sinusitis.

WHO TO FOLLOW